HIV-Positive Mothers Could Protect Newborns With Extended-Dose Nevirapine Treatment
Breastfeeding women can reduce the risk of HIV transmission to infants using an extended-dose regimen of nevirapine, according to an article released on July 25, 2008 in The Lancet. While highly active anti-retroviral therapy (HAART) can prevent vertical transmission when administered to pregnant women, but access to this therapy can be limited in certain regions where resources are limited.
More: continued here
Filed under: Pregnancy on July 31st, 2008